HPV16 E7 anticorps (Middle Region)
Aperçu rapide pour HPV16 E7 anticorps (Middle Region) (ABIN2173795)
Antigène
Voir toutes HPV16 E7 (HPV-16 E7) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Specificité
- This antibody may also detect HPV35-E7
-
Réactivité croisée
- Humain, Virus
-
Réactivité croisée (Details)
- HPV16
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from middle of HPV16-E7
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
WB 1:100-1000
IHC-P 1:100-500
IF(IHC-P) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Date de péremption
- 12 months
-
-
-
: "Targeting hexokinase 2 inhibition promotes radiosensitization in HPV16 E7-induced cervical cancer and suppresses tumor growth." dans: International journal of oncology, Vol. 50, Issue 6, pp. 2011-2023, (2017) (PubMed).
: "HPV16 E6/E7 upregulates HIF-2α and VEGF by inhibiting LKB1 in lung cancer cells." dans: Tumour biology, Vol. 39, Issue 7, pp. 1010428317717140, (2017) (PubMed).
-
: "Targeting hexokinase 2 inhibition promotes radiosensitization in HPV16 E7-induced cervical cancer and suppresses tumor growth." dans: International journal of oncology, Vol. 50, Issue 6, pp. 2011-2023, (2017) (PubMed).
-
- HPV16 E7 (HPV-16 E7) (Human Papilloma Virus 16 E7 (HPV-16 E7))
-
Classe de substances
- Viral Protein
-
Sujet
-
Synonyms: Protein E7, E7
Background: Plays a role in viral genome replication by driving entry of quiescent cells into the cell cycle. Stimulation of progression from G1 to S phase allows the virus to efficiently use the cellular DNA replicating machinery to achieve viral genome replication. E7 protein has both transforming and trans-activating activities. Induces the disassembly of the E2F1 transcription factor from RB1, with subsequent transcriptional activation of E2F1-regulated S-phase genes. Interferes with host histone deacetylation mediated by HDAC1 and HDAC2, leading to transcription activation. Plays also a role in the inhibition of both antiviral and antiproliferative functions of host inteferon alpha.
-
ID gène
- 1489079
-
UniProt
- P03129
Antigène
-